Trial Profile
A Retrospective Study Assessing the Impact of Initiating Long-Acting Injectables on All-Cause and Psychiatric Hospitalization in Patients with Bipolar I Disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 May 2018
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Fluphenazine; Haloperidol; Paliperidone; Risperidone
- Indications Bipolar I disorders
- Focus Therapeutic Use
- 25 May 2018 New trial record
- 23 May 2018 Results presented at the 23rd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.